Trials / Completed
CompletedNCT03193879
Effects of Particulate Matter on the Pulmonary Function and Acute Exacerbation of COPD and Asthma
Effects of Particulate Matter on the Lung Function and Acute Exacerbation of COPD and Asthma Patients--A Multi-center Cohort Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 505 (actual)
- Sponsor
- Peking Union Medical College Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
Particulate matter(PM) exposure has been shown to increase the morbidity and mobility of a variety of respiratory diseases, including COPD and asthma. This study focus on the effects of PM on the pulmonary function and acute exacerbation of COPD and asthma patients in China, where PM exposure is much heavier than the United States and European countries.
Detailed description
Particulate matter(PM) exposure has been shown to increase the morbidity and mobility of a variety of respiratory diseases, including COPD and asthma. This study focus on the effects of PM on the pulmonary function and acute exacerbation of COPD and asthma patients in China, where PM exposure is much heavier than the United States and European countries. This study is an observational study which lasts 3 years. Primary outcome measures:Change in spirometry (FEV1) of COPD, asthma patients and healthy volunteers in response to different exposure doses of PM.
Conditions
Timeline
- Start date
- 2015-12-01
- Primary completion
- 2021-09-01
- Completion
- 2021-09-01
- First posted
- 2017-06-21
- Last updated
- 2021-09-21
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03193879. Inclusion in this directory is not an endorsement.